Low Leverage / Strong Balance SheetMinimal reported debt and sizable equity provide durable solvency resilience, lowering near-term refinancing risk. This structural strength preserves optionality for continued R&D, partnerships or capital raises and gives management time to pursue commercialization without imminent liquidity pressure.

Accelerating Revenue GrowthSharply accelerating revenue across recent years signals improving commercial traction for the firm's X‑ray technology. Sustained top-line momentum supports scaling economics, validation with customers, and a clearer pathway to covering fixed costs if growth continues over the next several quarters.

Favorable Industry ExposureOperating in the medical devices sector provides structural demand stability from healthcare spending and diagnostic needs. Durable end‑markets and recurring replacement/upgrade cycles support longer‑term revenue opportunities for imaging and X‑ray technologies versus cyclical consumer sectors.

Bears Say

Persistent Net LossesLarge, persistent net losses indicate the business is not yet generating sustainable profit and are eroding retained capital. Over months this forces repeated external funding or equity dilution, limits reinvestment capacity, and raises execution risk until a durable profit improvement is achieved.

Consistent Negative Operating Cash FlowMaterially negative operating cash flow across periods shows the company consumes cash to run operations. This structural cash burn creates reliance on financing, constrains strategic flexibility, and increases the risk that commercial gains are undermined by liquidity shortfalls before break‑even.

Volatile And Negative Gross MarginsVolatile or negative gross margins point to pricing, production or product‑mix issues that undermine operating leverage. Without stable positive gross margins, revenue growth alone cannot translate into sustainable profits, making durable margin recovery essential for long‑term viability.

LXB FAQ

What was Luxbright AB’s price range in the past 12 months?

Luxbright AB lowest stock price was kr0.37 and its highest was kr0.94 in the past 12 months.

What is Luxbright AB’s market cap?

Luxbright AB’s market cap is kr57.27M.

When is Luxbright AB’s upcoming earnings report date?

Luxbright AB’s upcoming earnings report date is Aug 14, 2026 which is in 178 days.

How were Luxbright AB’s earnings last quarter?

Luxbright AB released its earnings results on Jan 30, 2026. The company reported -kr0.071 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.071.

Is Luxbright AB overvalued?

According to Wall Street analysts Luxbright AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luxbright AB pay dividends?

Luxbright AB does not currently pay dividends.

What is Luxbright AB’s EPS estimate?

Luxbright AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Luxbright AB have?

Luxbright AB has 130,148,010 shares outstanding.

What happened to Luxbright AB’s price movement after its last earnings report?

Luxbright AB reported an EPS of -kr0.071 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.828%.

Which hedge fund is a major shareholder of Luxbright AB?

Currently, no hedge funds are holding shares in SE:LXB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Luxbright AB

Luxbright AB (publ), a technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. The company was incorporated in 2012 and is headquartered in Gothenburg, Sweden.